BARCLAYS PLC

Position in ADCT — ADC Therapeutics SA

CIK 312069 LONDON, X0

Position in ADCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$100,861

-$72,894 QoQ

Shares Held

94,264

+103.4% QoQ

Ownership

0.074%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#45

of 113 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. ADCT ranks #37 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	2,302,737	$165,474,680
2	NBIX	Neurocrine Biosciences Inc	324,807	$54,742,970
3	TEVA	Teva Pharmaceutical Industries Ltd	1,343,554	$45,519,608
4	UTHR	UNITED THERAPEUTICS Corp	72,010	$39,017,177
5	VTRS	Viatris Inc	2,437,004	$38,699,622
6	INDV	Indivior Pharmaceuticals, Inc.	907,024	$37,215,193
7	HIMS	Hims & Hers Health, Inc.	861,006	$29,851,076
8	ALKS	Alkermes plc.	219,935	$11,524,592

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$100,861	94,264	+103.4%	Shares	Defined	2026-08-14
2026-03-31	$173,755	46,335	-71.3%	Shares	Defined	2026-05-15
2025-12-31	$569,692	161,386	+23.7%	Shares	Sole	2026-02-13
2025-09-30	$521,840	130,460	-10.3%	Shares	Sole	2026-03-31
2025-06-30	$389,690	145,407	+43.9%	Shares	Sole	2026-02-27
2025-03-31	$142,457	101,034	-28.6%	Shares	Sole	2026-03-17
2024-12-31	$281,575	141,495	+10.8%	Shares	Sole	2026-03-19
2024-09-30	$402,377	127,739	+277.4%	Shares	Sole	2026-03-31
2024-06-30	$106,962	33,849	-89.3%	Shares	Sole	2026-03-23
2023-06-30	$677,088	314,925	-5.8%	Shares	Sole	2026-03-27
2023-03-31	$651,830	334,272	—	Shares	Sole	2026-03-30
No filing history on record for this holder in this stock.